The transition to value-based care allows clinicians to focus on a few common areas instead of multiple measures for different payers, explained Kate Goodrich, MD, director of the Quality Measurement and Value-Based Incentives Group in CMS.
The transition to value-based care allows clinicians to focus on a few common areas instead of multiple measures for different payers, explained Kate Goodrich, MD, director of the Quality Measurement and Value-Based Incentives Group in CMS.
Transcript (slightly modified)
CMS, AHIP, and other organizations have announced 7 core sets of quality measures. How does the implementation of these core sets of quality measures help the transition to value-based payments?
The transition to value-based care isn’t just happening from CMS alone. Commercial payers are also transitioning to value-based care. Think about it, if you’re a doctor in a practice, small or large, and you have a contract with five or seven different payers in your market, plus you see Medicare patients and you see Medicaid patients, you may be responding to multiple different sets of quality measures that aren’t aligned, and think about the burden that puts on you to have to do that.
So if we can get the quality measures for, let’s just say a primary care physician, or an oncologist, aligned across payers, they are responding to all of the same incentives for where they need to improve the quality of care they deliver. That is much more likely to actually lead to improvement in care for those patients, because physicians, anybody, can’t focus on 30 different areas to improve. And if you’re reporting on 30 different measures for five or seven different payers, there’s no way you can actually truly improve in any one area.
But if we can narrow that to a few common areas that are most important for patients and most relevant for doctors, the chances that you actually can significantly improve care for patients goes up dramatically. That is what the transition to value-based care is all about. It’s all about improving outcomes for patients in a more efficient manner, and improving the patient experience. The payers just have to be aligned in those incentives in order for this to be successful.
IgE Mediation in Pediatric Atopic Dermatitis, Concurrent Immune Disorders: Amy Paller, MD
August 4th 2025Amy Paller, MD, pediatric dermatologist and clinical researcher at Northwestern Medicine's Feinberg School of Medicine, discussed the potential impact of reducing immunoglobulin E (IgE) levels in pediatric patients with atopic dermatitis.
Read More
It Take a Village in Cancer Care: A Q&A With David Nguyen, MD
July 23rd 2025David Nguyen, MD, medical oncologist with Tufts Medicine and Lowell General Hospital, discusses the evolving landscape of advanced cancer treatments like chimeric antigen receptor T-cell therapy and bispecific antibodies
Read More
Best of Managed Care Cast: Top 5 Episodes From the First Half of 2025
July 18th 2025These interviews are the top episodes, by listens, from among the 21 podcast episodes The American Journal of Managed Care® produced over the first half of 2025. Give them all another listen, and perhaps learn something new.
Read More